- India
- /
- Healthcare Services
- /
- NSEI:SHALBY
Returns On Capital At Shalby (NSE:SHALBY) Paint A Concerning Picture
What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly, we'll want to see a proven return on capital employed (ROCE) that is increasing, and secondly, an expanding base of capital employed. Basically this means that a company has profitable initiatives that it can continue to reinvest in, which is a trait of a compounding machine. Having said that, from a first glance at Shalby (NSE:SHALBY) we aren't jumping out of our chairs at how returns are trending, but let's have a deeper look.
What is Return On Capital Employed (ROCE)?
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Shalby, this is the formula:
Return on Capital Employed = Earnings Before Interest and Tax (EBIT) รท (Total Assets - Current Liabilities)
0.086 = โน880m รท (โน12b - โน1.6b) (Based on the trailing twelve months to December 2021).
So, Shalby has an ROCE of 8.6%. In absolute terms, that's a low return and it also under-performs the Healthcare industry average of 19%.
See our latest analysis for Shalby
Above you can see how the current ROCE for Shalby compares to its prior returns on capital, but there's only so much you can tell from the past. If you'd like to see what analysts are forecasting going forward, you should check out our free report for Shalby.
What Can We Tell From Shalby's ROCE Trend?
On the surface, the trend of ROCE at Shalby doesn't inspire confidence. To be more specific, ROCE has fallen from 11% over the last five years. However, given capital employed and revenue have both increased it appears that the business is currently pursuing growth, at the consequence of short term returns. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run.
The Bottom Line On Shalby's ROCE
Even though returns on capital have fallen in the short term, we find it promising that revenue and capital employed have both increased for Shalby. However, total returns to shareholders over the last three years have been flat, which could indicate these growth trends potentially aren't accounted for yet by investors. So we think it'd be worthwhile to look further into this stock given the trends look encouraging.
One more thing to note, we've identified 1 warning sign with Shalby and understanding this should be part of your investment process.
While Shalby may not currently earn the highest returns, we've compiled a list of companies that currently earn more than 25% return on equity. Check out this free list here.
New: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
โข Connect an unlimited number of Portfolios and see your total in one currency
โข Be alerted to new Warning Signs or Risks via email or mobile
โข Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NSEI:SHALBY
Shalby
Engages in the operation of multi-specialty hospitals primarily in India, the United States, Japan, Indonesia, Oman, the United Arab Emirates, Bangladesh, Nepal, and internationally.
Reasonable growth potential with adequate balance sheet.